In the BioHarmony Drug Report Database

"Preview" Icon

Rasagiline

Azilect, Rasagiline ratiopharm (rasagiline) is a small molecule pharmaceutical. Rasagiline was first approved as Azilect on 2005-02-21. It is used to treat parkinson disease in the USA. It has been approved in Europe to treat parkinson disease. The pharmaceutical is active against amine oxidase [flavin-containing] B. In addition, it is known to target hypothetical protein. Azilect’s patents are valid until 2027-08-27 (FDA).

 

Trade Name

 

Azilect, Rasagiline ratiopharm
 

Common Name

 

rasagiline
 

ChEMBL ID

 

CHEMBL887
 

Indication

 

parkinson disease
 

Drug Class

 

Mao inhibitors, type B

Image (chem structure or protein)

Rasagiline structure rendering